Charles Conway
Nessuna posizione attualmente
Profilo
Il Dr. Charles Conway è un direttore scientifico della Biohaven Pharmaceutical Holding Co. Ltd. Il Dr. Conway è stato precedentemente impiegato come Associate Director-Biology Analytics presso la Bristol Myers Squibb Co. Ha conseguito la laurea presso la University of Central Missouri, una laurea presso la University of California San Diego e un dottorato presso la University of California, Santa Barbara.
Precedenti posizioni note di Charles Conway
| Società | Posizione | Fine |
|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Chief Tech/Sci/R&D Officer | 03/10/2022 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2017 |
Formazione di Charles Conway
| University of Central Missouri | Undergraduate Degree |
| University of California San Diego | Graduate Degree |
| University of California, Santa Barbara | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Aziende private | 1 |
|---|---|
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
- Borsa valori
- Insiders
- Charles Conway
